Search
for

    Sort by

    Research 721–750 of 1000+

    1. A Natural Inhibitor, 1′S-1′-Acetoxychavicol Acetate, Against Testosterone-Induced Alopecia via NADPH Oxidase Regulation Molecules · 2025
    2. Computational drug discovery of potential 5α-reductase phytochemical inhibitors and hair growth promotion using in silico techniques Frontiers in Bioinformatics · 2025
    3. Table 2_Computational drug discovery of potential 5α-reductase phytochemical inhibitors and hair growth promotion using in silico techniques.xlsx OPAL (Open@LaTrobe) (La Trobe University) · 2025
    4. Table 1_Computational drug discovery of potential 5α-reductase phytochemical inhibitors and hair growth promotion using in silico techniques.xlsx OPAL (Open@LaTrobe) (La Trobe University) · 2025
    5. Oral and Topical Janus Kinase Inhibitors in Patients With Cutaneous T‐Cell Lymphoma: A Real‐World Single‐Center Experience The Journal of Dermatology · 2025
    6. Real-world Effectiveness and Safety of Janus Kinase Inhibitors in Alopecia Areata: A Retrospective Cohort Study of 72 Patients Acta Dermato Venereologica · 2025
    7. Differential association between cumulative dose of 5α-reductase inhibitors and mortality Scientific Reports · 2025
    8. Drug Discovery Insights from a Computational QSAR Study on Alpha-Reductase Inhibitors and Layered Double Hydroxides Electrocatalysts International Journal For Multidisciplinary Research · 2025
    9. In Vitro Skin Penetration of 5α-Reductase Inhibitors from Tectona grandis L.f. Leaf Extracts Molecules · 2025
    10. The Use of Janus Kinase Inhibitors for Primary Neutrophilic Cicatricial Alopecias International Journal of Trichology · 2025
    11. 5-Alpha Reductase Inhibitors on Hypersexuality During the Manic Phase of Bipolar and Psychotic Patients; New Insight to a Well-Known Medicines Iranian journal of pharmaceutical research · 2025
    12. Risk associated with the use of 5-alpha reductase inhibitors with minoxidil in treatment of male androgenetic alopecia – literature review Journal of Pre-Clinical and Clinical Research · 2025
    13. Using 5 alpha reductase inhibitors safely: What primary care physicians need to know Journal of Family Medicine and Primary Care · 2024
    14. Effect of 5-alpha reductase inhibitors in animal models of Parkinson’s disease Frontiers in Neuroendocrinology · 2024
    15. 5-Alpha-Reductase Inhibitors in the Treatment of Male Androgenetic Alopecia: Clinical Experience Health of Man · 2024
    16. Risk of Estrogen-Driven Malignancies in Females on 5-alpha Reductase Inhibitors Research Square (Research Square) · 2024
    17. A linear and reticulate crusted keratotic papulopustular eruption: a rare presentation of PRIDE (Papulopustules and/or paronychia, Regulatory abnormalities of hair growth, Itching, and Dryness due to Epidermal growth factor receptor inhibitors) complex Postgraduate Medical Journal · 2024
    18. Intraoperative Iris Behavior during Phacoemulsification Maneuvers in Rabbits Treated with Selective α1-Blocker, 5α-Reductase Inhibitor, or Anxiolytic Medication Journal of Personalized Medicine · 2024
    19. LB891 Analysis of breast health outcomes in women on oral 5-alpha reductase inhibitors: A single-center retrospective cohort study Journal of Investigative Dermatology · 2024
    20. Hair Growth Promoting Effects of 15-Hydroxyprostaglandin Dehydrogenase Inhibitor in Human Follicle Dermal Papilla Cells International Journal of Molecular Sciences · 2024
    21. Differential Association Between Cumulative Dose of 5α-Reductase Inhibitors and Mortality 2024
    22. Risk of age-related macular degeneration in men receiving 5α-reductase inhibitors: a population-based cohort study Age and Ageing · 2024
    23. Is There an Association between 5a Reductase Inhibitors and Metabolic Syndrome? A Narrative Review of the Literature Reviews on Recent Clinical Trials · 2024
    24. Recent trends in nanocarrier formulations of actives beyond minoxidil and 5-α reductase inhibitors in androgenetic alopecia management: A systematic review Journal of Drug Delivery Science and Technology · 2024
    25. Adverse effects of the 5-alpha-reductase inhibitor finasteride on Daphnia magna: Endocrine system and lipid metabolism disruption Ecotoxicology and Environmental Safety · 2024
    26. Safety and patient-reported outcomes in patients with hormone receptor-positive, HER2-negative advanced breast cancer treated with CDK4/6 inhibitors in China: A cross-sectional study. Journal of Clinical Oncology · 2024
    27. JAK kinase pathway inhibitor drugs in patients with moderate-to-severe alopecia: a real-world experience e_Buah · 2024
    28. Association of 5α-Reductase Inhibitors with Depression and Suicide: A Mini Systematic Review and Meta-analysis European urology focus · 2024
    29. Emerging and traditional 5-α reductase inhibitors and androgen receptor antagonists for male androgenetic alopecia Expert opinion on emerging drugs · 2024
    30. MP31-04 HOW DO 5-ALPHA-REDUCTASE INHIBITORS CHANGE PSA DENSITY IN PATIENTS ON ACTIVE SURVEILLANCE? 2024